Airsupra™ is a first-in-class combination rescue inhaler containing both a short-acting beta2-agonist (SABA) and an inhaled corticosteroid (ICS) for the as-needed treatment or prevention of asthma symptoms in people aged 18 years and older. It delivers:

• Albuterol sulfate 90 mcg (base) – a fast-acting bronchodilator that quickly relieves bronchospasm

• Budesonide 80 mcg – a corticosteroid that helps reduce airway inflammation

Unlike traditional rescue inhalers, Airsupra™ addresses both immediate symptoms and the underlying inflammation, offering a more complete approach to managing asthma flare-ups.

Features:

• Dual-action formulation: relieves and controls

• Rapid-acting SABA (albuterol) + anti-inflammatory ICS (budesonide)

• Metered-dose inhaler (MDI) with dose counter

• Used as needed, not on a fixed schedule

• Designed to reduce the risk of future asthma attacks